Inmed provides business update and milestones for 2023

Vancouver, british columbia, jan. 10, 2023 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlines key accomplishments from 2022 and provides business update and catalysts for 2023.

INM Ratings Summary

INM Quant Ranking